Moderately bullish activity in Pfizer (PFE), with shares up 22c, or 0.82%, near $27.79. Options volume roughly in line with average with 70k contracts traded and calls leading puts for a put/call ratio of 0.4, compared to a typical level near 0.55. Implied volatility (IV30) is higher by 0.6 points near 26.24,and above the 52wk median, suggesting an expected daily move of $0.46. Put-call skew steepened, indicating increased demand for downside protection.Looking ahead: Pfizer (PFE) will report earnings after the close on None.Option markets are pricing in a 50% probability of a move greater than 0.0% or $0.00.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on PFE:
- Astellas, Pfizer announce FDA grants priority review to PADCEV, Keytruda sBLA
- Pfizer Faces Patent Cliff As New Cancer Bets Grow
- Kailera Stock (KLRA) Rockets 68% after IPO in Race for $150B Obesity Market
- Trump names Erica Schwartz CDC Director
- Pfizer-Backed EV-209 Trial Targets Bladder Preservation in High-Need Cancer Segment
